期刊文献+

心肌缺血及再灌注大鼠血浆蛋白C活性变化的实验研究 被引量:1

Experimental study on the changes of protein C activity in plasma with myocardial ischemia and reperfusion in rats
下载PDF
导出
摘要 目的:探讨心肌缺血及再灌时大鼠血浆蛋白C(PC)活性及血小板聚集率的变化和意义。方法:SD雄性大鼠40只,随机分为对照组(C,n=8)、缺血组(I,n=24)和缺血再灌组(IR,n=8),缺血组按照造模后缺血时间的不同又分别分为缺血10 min(I10)、30 min(I30)及60 min(I60)组,每组8只。采用可逆性阻断大鼠左冠状动脉前降支的方法制备心肌缺血及再灌注模型,实验结束后即刻颈总动脉取血,以发色底物法检测血浆蛋白C活性,比浊法测定血小板聚集率。结果:心肌缺血模型组大鼠血浆PC活性均明显低于对照组(P<0.01),且随心肌缺血时间延长降低;缺血再灌组PC活性略有恢复,但仍低于对照组(P<0.01)。血小板聚集率缺血10 min、缺血30 min组及IR组较对照组均明显升高(P<0.01),而缺血60 min组血小板聚集率与对照组比较无统计学意义。结论:心肌缺血及再灌注损伤可引起PC活性下降,PC活性的变化参与了心肌缺血及损伤的过程,较血小板聚集率敏感。因此,PC活性的变化有可能成为对评价缺血性心血管疾病有预报价值的指标。 AIM:To investigate the clinical significance of plasma levels of protein C(PC) and platelet aggregation in rats with myocardial ischemia and reperfusion injury. METHODS:40 male SD rats were randomly divided into groups of control(C,n=8),ischemia(I,n=24) and ischemia-reperfusion(IR,n=8).The ischemia groups were divided into 10 min(I10),30 min(I30) and 60 min group(I60) respectively,8 rats in each group.The rat model of myocardial ischemia and reperfusion was prepared by the left anterior descending coronary artery reversible occlusion.Blood samples were collected from the carotid artery immediately.The plasma PC activity and platelet aggregation were detected by chromogenic substrate assay and turbidity assay,respectively.RESULTS:Plasma PC activities in myocardial ischemia rats were significantly lower than those in the control(P0.05),and there is a negative relation between the decrease of PC activity and ischemia time;plasma PC activities in ischemia-reperfusion rats were slightly recovered,but still lower than those in the control(P0.01).The platelet aggregation in ischemia 10 min,30 min ischemia and IR rats were significantly higher than those in the control(P0.01),while ischemia 60 min platelet aggregation showed no statistical significance compared with the control group.CONCLUSION:Myocardial ischemia and reperfusion injury can result in PC activities loss.These suggest that the decrease of PC activity may be involved in myocardial ischemia and injury,more sensitive than platelet aggregation.Therefore,the PC activity maybe a predictive indicator for ischemic cardiovascular disease.
出处 《中国临床药理学与治疗学》 CAS CSCD 2010年第9期1012-1015,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 安徽省高教青年教师资助计划基金项目(2007JQ1172)
关键词 蛋白C 心肌缺血再灌注损伤 血小板聚集率 Protein C Myocardial ischemia and reperfusion injury Platelet aggregation
  • 相关文献

参考文献10

  • 1Ripley TL, Nutescu E. Anticoagulation in patients with heart failure and normal sinus rhythm[J]. Am J Health Syst Pharm,2009,66(2):134--141.
  • 2Nair A, Sealove B, Hatperin JL, et aL Anticoagulation in patients with heart failure., who, when, and why[J] ? Eur Heart J, 2006 (Supplenent E), 8 : E32--E38.
  • 3Altinisik J,Ates O, Ulutin T,et al. Factor V Leiden, prothrombin G20210A, and protein C mutation {requency in Turkish venous thrombosis patients[J]. Clin Appl Thromb Hemost, 2008, 14 (4) :415--420.
  • 4朱广瑾,王凌燕,段岩平,张莹.大鼠心肌缺血及再灌时血浆蛋白C的变化[J].基础医学与临床,1994,14(5):52-55. 被引量:4
  • 5Raivio P, Ferndndez JA, Kuitunen A,et al. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery[J]. J Thorac Cardiovasc Surg, 2007,133(1):44--51.
  • 6Toulon P, Smirnov M, Triscott M, et al. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multieenter study [J]. Thromb Res, 2009,124(1):137--143.
  • 7张根葆,陈冬云,周志泳,李爱华,桂常青,陆晓华.蝮蛇毒蛋白C激活物的纯化与抗血小板活性[J].皖南医学院学报,2005,24(1):8-10. 被引量:25
  • 8Mahmoodi BK,Brouwer JP, Veeger N, et al. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. [J]. Circulation,2008,118(16) : 1659 -- 1667.
  • 9Loubele STB,Spek CA, Leenders A,et al. Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation [J]. Arterioscler Thromb Vasc Biol, 2009,29(7) : 1087-- 1092.
  • 10王宗奎,林方昭,肖小璞,李长清.蛋白C、蛋白S的研究与应用[J].中国输血杂志,2010,23(4):322-326. 被引量:14

二级参考文献61

共引文献38

同被引文献13

  • 1张根葆,陈冬云,周志泳,李爱华,桂常青,陆晓华.蝮蛇毒蛋白C激活物的纯化与抗血小板活性[J].皖南医学院学报,2005,24(1):8-10. 被引量:25
  • 2符民桂.蛇毒蛋白C活化剂的研究进展[J].国外医学(输血及血液学分册),1996,19(6):367-369. 被引量:9
  • 3Stocker K,Fisher H,Meier J,et al.Characteriza-tion of the protein C activator Protac from the ven-om of the southem copperhead(Agkistrodon contor-trix)snake[J].Toxicon,1987,25(3):239-243.
  • 4Klein JD,Walker FJ.Purification of a protein C ac-tivator from the venom of the southern copperheadsnake(Agkistrodon contortrix)[J].Biochemistry,1986,25(15):4175-4179.
  • 5Kogan AE,Makarow AN,Bobruskin ID,et al.Comparative study of protein C activators from theAgkistrodon snake venoms[J].Thromb Res,1991,62(6):775-780.
  • 6Strukova SM,Kogan AE,Tara A,et al.Anticoag-ulant effect of the protease from Agkistrodon venommediated by protein C activation in rats[J].ThrombRes,1989,55(1):149-153.
  • 7EPA OPPTS.Harmonized Test Guideline 870.1100Acute Oral Toxicity[S].1998.
  • 8OECD.Guidelines for the testing of chemicals.Guideline 425:Acute oral toxicity-up-and-downprocedure[S].2001:1-26.
  • 9SFDA.化学药物急性毒性试验技术指导原则[S].GPT1-1.2005.
  • 10Rispin A,Farrar D,Macgosches E,et al.Alterna-tive methods for the median lethal dose(LD(50))test:the up-and-down procedure for acute oral tox-icity[J].ILAR J,2002,43(4):233-243.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部